<DOC>
	<DOCNO>NCT01404078</DOCNO>
	<brief_summary>This randomize double blind 2x2 factorial control trial evaluate efficacy tolerability low strength Polycap versus two dos low strength Polycap patient stable cardiovascular disease reduce blood pressure LDL . To evaluate tolerability safety low dose potassium supplementation compare placebo patient stable cardiovascular disease . Approximately 500 patient plan randomize .</brief_summary>
	<brief_title>Study Compare 2 Doses Polycap Versus Single Dose Polycap With Without Pottasium</brief_title>
	<detailed_description>Mean change blood pressure take 2capsules polycap versus one Difference Rates early discontinuation 2 capsule polycap versus one Rates report adverse effect among take polycap</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>1 . Individuals 40 year , seat blood pressure &gt; 130/80 mm Hg two consecutive reading ( BP &gt; 120/80 mm Hg patient treatment 2 antihypertensive medication ) one follow 1 . Coronary artery disease ; previous myocardial infarction ( &gt; 7 day post uncomplicated MI ) , 2 . Ischemic heart disease significant ECG change positive stress test , 3 . Stable angina unstable angina document evidence multivessel ( angiography ECG CT angiography ) coronary artery disease , 4 . PTCA CABG Surgery &gt; 30 day inform consent . 5 . Cerebrovascular disease ; Previous Ischemic stroke Transient Ischemic Attacks &gt; 30 day inform consent . 6 . High risk diabetes mellitus define HbA1C &gt; 7.5 % , microalbuminuria blood pressure &gt; 140/90 mm Hg . 7 . Peripheral artery disease define current prior history : physician diagnose intermittent claudication vascular surgery atherosclerotic disease ankle/arm systolic blood pressure ratio ≤ 0.90 either leg rest , angiographic doppler study demonstrate ≥ 70 % stenosis noncardiac artery . 2 . Those provide informed consent comply medication followup visit . 1 . Known hypersensitivity intolerance study medication clear indication full dose beta blocker , RAAS blocker ( ACEi , ARBs , Renin inhibitor , etc . ) , diuretic statin . 2 . History bleed hemorrhagic stroke anytime past need continue anticoagulation therapy . 3 . Patients indication high dos aspirin need 75mg clopidogrel daily . 4 . Have significant bradycardia ( heart rate &lt; 50 beats/min ) second thirddegree heart block without pacemaker . 5 . Planned cardiac surgery PTCA noncardiac surgery &lt; 3months eligibility assessment . 6 . Heart transplant recipient . 7 . Renal dysfunction define serum creatinine &gt; 2 mg/dL and/or serum potassium &gt; 5.0 mEq/L . 8 . Patients age &gt; 70 year , mild renal dysfunction define serum creatinine &gt; 124 µmol/L ( 1.4 mg/dL ) eGFR &lt; 45 ml/min/1.73 m2 . 9 . Hepatic dysfunction , SGOT SGPT &gt; 3 x ULN . 10 . Taking another experimental drug within 30days last dose experimental drug . 11 . Peptic ulcer disease bleed , bleed diathesis . 12 . Bronchial asthma Chronic Obstructive Pulmonary Disease asthma . 13 . Gout , rheumatoid arthritis chronic inflammatory disease require longterm medication NSAIDs . 14 . Any history muscular pain , pathology muscle past history muscular pain secondary taking statin fibrates . 15 . Pregnancy lactate woman childbearing potential inadequate contraception . 16 . Inability attend follow visit ( due significant disability , inadequate address contact detail , subject far place , psychiatric illness etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>